Canada Medical Cannabis Market, by Derivative, 2018-2027

Growth Outlook

• The 2027 portion of the Canada Medical Cannabis Market, by Derivative, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 3553 Mn in 2026 and is projected to reach USD 3912 Mn by 2027 — a gain of about 10% over the forecast period, translating to a CAGR in the double digits.
• Canada's medical cannabis market has seen significant growth in recent years, fueling demand for various derivatives of the plant. These derivatives include cannabis oils, capsules, topical creams, and edibles, among others.
• What the regional split looks like (2026): Cannabidiol leads, holding roughly 72% of segment value — the single largest regional share. Tetrahydrocannabinol is the second-largest contributor.
• By 2027, Cannabidiol alone is expected to reach USD 2825 Mn, with Tetrahydrocannabinol at USD 1087 Mn.

Market Dynamics

Canada's medical cannabis market has seen significant growth in recent years, fueling demand for various derivatives of the plant. These derivatives include cannabis oils, capsules, topical creams, and edibles, among others. One of the most prominent derivatives in demand is cannabis oil. This is a concentrated form of cannabis that is extracted from the plant and contains a high percentage of CBD (cannabidiol) and THC (tetrahydrocannabinol). Medical cannabis users often prefer cannabis oil over other forms, as it provides a more controlled and consistent dosage. It is also more discreet and can be easily incorporated into daily routines. Another thriving derivative in the Canadian medical cannabis market is capsules. These are oral medications that contain cannabis oil or other forms of the plant. Capsules offer a convenient and discreet way to consume medical cannabis, especially for those who do not wish to smoke or vaporize the plant. They also provide a consistent dosage, making it easier for patients to track their intake and manage their symptoms. Cannabis topical creams and ointments have also gained popularity in the medical cannabis market. These products are applied directly to the skin and are primarily used for pain relief and inflammation.

They are preferred by patients who do not want to ingest cannabis or have specific areas of pain or discomfort that need targeted treatment. Edibles, such as cookies, candies, and drinks, have become increasingly sought after in the medical cannabis market. These products offer an alternative to smoking or vaping and provide a discreet way to consume cannabis. Edibles also provide a longer-lasting effect compared to other forms of cannabis, making them appealing to patients who require extended relief. Cannabis derivatives have also made their way into the beauty and wellness industry. This includes CBD-infused skincare products, bath bombs, and essential oils. These products are not only in demand for their potential therapeutic benefits but also for their natural and organic properties. In addition to the various derivatives mentioned above, there is also a growing demand for custom-made products that cater to specific medical conditions and symptoms. For instance, medical cannabis companies are developing strains and products specifically for pain, anxiety, sleep, and inflammation. This personalized approach is driven by the increasing awareness and understanding of the therapeutic properties of cannabis and its derivatives.

In conclusion, Canada's medical cannabis market is not only seeing growth in the traditional forms of the plant but also in the demand for its various derivatives. These derivatives offer alternative and convenient ways to consume cannabis and provide targeted relief for a variety of medical conditions. With the continuous development and innovation in this sector, it is evident that the demand for medical cannabis derivatives in Canada will continue to rise.

Research Methodology

Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2024.